DOUBLE-BLIND CONTROLLED-STUDY OF PERGOLIDE MESYLATE IN THE TREATMENT OF PARKINSONS-DISEASE

被引：40

作者：

OLANOW, CW ^{[1
]}

ALBERTS, MJ ^{[1
]}

机构：

[1] DUKE UNIV,MED CTR,DEPT MED NEUROL,DURHAM,NC 27710

来源：

CLINICAL NEUROPHARMACOLOGY | 1987年 / 10卷 / 02期

关键词：

D O I：

10.1097/00002826-198704000-00009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：178 / 185

页数：8

共 29 条

[1] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS [J].

CORRODI, H ;

FUXE, K ;

HOKFELT, T ;

LIDBRINK, P ;

UNGERSTEDT, U .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :409-412

[2] DOUBLE-BLIND TRIAL OF PERGOLIDE FOR PARKINSONS-DISEASE [J].

DIAMOND, SG ;

MARKHAM, CH ;

TRECIOKAS, LJ .

NEUROLOGY, 1985, 35 (03) :291-295

[3] PERGOLIDE-INDUCED CIRCLING IN RATS WITH 6-HYDROXYDOPAMINE LESIONS IN THE NIGROSTRIATAL PATHWAY [J].

DUVOISIN, RC ;

HEIKKILA, RE ;

MANZINO, L .

NEUROLOGY, 1982, 32 (12) :1387-1391

[4] CHRONIC AGONIST THERAPY FOR PARKINSONS-DISEASE - A 5-YEAR STUDY OF BROMOCRIPTINE AND PERGOLIDE [J].

GOETZ, CG ;

TANNER, CM ;

GLANTZ, RH ;

KLAWANS, HL .

NEUROLOGY, 1985, 35 (05) :749-751

[5] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS [J].

GOLDSTEIN, M ;

LIEBERMAN, A ;

LEW, JY ;

ASANO, T ;

ROSENFELD, MR ;

MAKMAN, MH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3725-3728

[6]

Ilson J, 1983, Adv Neurol, V37, P85

[7]

Ilson J, 1984, Adv Neurol, V40, P395

[8] LONG-TERM STUDY OF PERGOLIDE IN PARKINSONS-DISEASE [J].

JANKOVIC, J .

NEUROLOGY, 1985, 35 (03) :296-299

[9]

KOLLER WC, 1980, NEUROPHARMACOLOGY, V19, P832

[10] LONG-TERM EXPERIENCE WITH PERGOLIDE THERAPY OF ADVANCED PARKINSONISM [J].

KURLAN, R ;

MILLER, C ;

LEVY, R ;

MACIK, B ;

HAMILL, R ;

SHOULSON, I .

NEUROLOGY, 1985, 35 (05) :738-742

← 1 2 3 →